The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Epidemiology of hepatitis C
Open accessAbstract
In the United States, the annual number of newly acquired acute hepatitis C virus (HCV) infections has declined from an estimated 180,000 in the mid 1980s to an estimated 28,000 in 1995. Approximately 25% to 30% of these infections are clinically apparent cases that are sufficiently symptomatic to gain medical attention. Deaths from fulminant hepatitis C are rare. The prevalence of antibody to HCV (anti- HCV) in the general population of the United States is 1.8%, corresponding to an estimated 3.9 million Americans infected with HCV, and an estimated 8,000 to 10,000 deaths each year result from HCV- associated chronic liver disease. HCV infection affects persons of all ages, but most acute cases of hepatitis C and the highest prevalence of anti-HCV are found among young adults. The highest proportion both of incident cases and prevalent infections is among whites, but the highest incidence and prevalence rates are among non-white racial/ethnic groups. In the past, transfusion of blood and blood products was an important source of HCV transmission, but currently, high-risk drug and sexual exposures account for most HCV transmission. Although the incidence of acute hepatitis C has declined, there is a large reservoir of chronically infected Americans who can serve as a source of transmission to others and who are at risk of the severe consequences of chronic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-6-835_3 · Cited by 1,155
(1999) · PsycEXTRA Dataset · doi:10.1037/e547812006-001 · Cited by 1,131
Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.655 · Cited by 690
Conry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Self-citationAach, R. D., Stevens, C. E., Hollinger, F. B., Mosley, J. W., Peterson, D. A., Taylor, P. E., Johnson, R. G., Barbosa, L. H., & Nemo, G. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251901 · Cited by 523
Epidemiology of Hepatitis C in the West
Alter, M. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007259 · Cited by 477
Self-citationImportance of Heterosexual Activity in the Transmission of Hepatitis B and Non-A, Non-B Hepatitis
Alter, M. J. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430090063034 · Cited by 435
Self-citation
Cited by
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Self-citationRising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Self-citationPoynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Epidemiology of hepatitis C virus infection
Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,339
Self-citationEvolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Davis, G. L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S. C., Trepo, C., Shiffman, M. L., Zeuzem, S., Craxi, A., Ling, M.-H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392102 · Cited by 1,282
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Gerlach, J. T., Diepolder, H. M., Jung, M., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R., Schirren, C. A., Santantonio, T., & Pape, G. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70353-7 · Cited by 714
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., & Wakita, T. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.023 · Cited by 590
Predictors of patient and graft survival following liver transplantation for hepatitis C
Charlton, M., Seaberg, E., Wiesner, R., Everhart, J., Zetterman, R., Lake, J., Detre, K., & Hoofnagle, J. (1998) · Hepatology · doi:10.1002/hep.510280333 · Cited by 537
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Self-citationViral Infections During Pregnancy
Silasi, M., Cardenas, I., Kwon, J., Racicot, K., Aldo, P., & Mor, G. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12355 · Cited by 500
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Clinical consequences of cytochrome P450 2C9 polymorphisms
KIRCHHEINER, J., & BROCKMOLLER, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.009 · Cited by 474
Romantic relationships and the physical and mental health of college students
BRAITHWAITE, S. R., DELEVI, R., & FINCHAM, F. D. (2010) · Personal Relationships · doi:10.1111/j.1475-6811.2010.01248.x · Cited by 424
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., Dalgard, O., Dillion, J. F., Flisiak, R., Forns, X., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02539.x · Cited by 411
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
Cerny, A., & Chisari, F. V. (1999) · Hepatology · doi:10.1002/hep.510300312 · Cited by 410
Bonkovsky, H. L., & Woolley, M. J. (1999) · Hepatology · doi:10.1002/hep.510290124 · Cited by 398
Genetic Epidemiology of Hepatitis C Virus throughout Egypt
Ray, S. C., Arthur, R. R., Carella, A., Bukh, J., & Thomas, D. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315786 · Cited by 375
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†
Everson, G. T., Trotter, J., Forman, L., Kugelmas, M., Halprin, A., Fey, B., & Ray, C. (2005) · Hepatology · doi:10.1002/hep.20793 · Cited by 357
Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., & Hahn, Y. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10323 · Cited by 333
Epidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
Zitzmann, N., Mehta, A. S., Carrouée, S., Butters, T. D., Platt, F. M., McCauley, J., Blumberg, B. S., Dwek, R. A., & Block, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11878 · Cited by 325
Viruses in the Mammalian Male Genital Tract and Their Effects on the Reproductive System
Dejucq, N., & Jégou, B. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.208-231.2001 · Cited by 324
George, J., Roulot, D., Koteliansky, V. E., & Bissell, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12719 · Cited by 322
Koh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Translational Control of Viral Gene Expression in Eukaryotes
Gale, M., Tan, S.-L., & Katze, M. G. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.239-280.2000 · Cited by 314
Hauser, P., Khosla, J., Aurora, H., Laurin, J., Kling, M. A., Hill, J., Gulati, M., Thornton, A. J., Schultz, R. L., Valentine, A. D., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001119 · Cited by 313
Bode, J. G., Ludwig, S., Ehrhardt, C., Erhardt, A., Albrecht, U., Schaper, F., Heinrich, P. C., & Häussinger, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-0664fje · Cited by 312
Cellular immune selection with hepatitis C virus persistence in humans
Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X.-H., Yang, H.-C., Sidney, J., Sette, A., Pardoll, D., Thomas, D. L., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050121 · Cited by 306
Yokota, T., Sakamoto, N., Enomoto, N., Tanabe, Y., Miyagishi, M., Maekawa, S., Yi, L., Kurosaki, M., Taira, K., Watanabe, M., et al. (2003) · EMBO reports · doi:10.1038/sj.embor.embor840 · Cited by 306
Diepolder, H. M., Gerlach, J. T., Zachoval, R., Hoffmann, R. M., Jung, M. C., Wierenga, E. A., Scholz, S., Santantonio, T., Houghton, M., Southwood, S., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.6011-6019.1997 · Cited by 301
Wang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 299
Hepatitis C Virus Infection in A Community in the Nile Delta: Risk Factors for Seropositivity
Habib, M., Mohamed, M. K., Abdel-Aziz, F., Magder, L. S., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Anwar, W., Strickland, T. G., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.20797 · Cited by 295
Hepatocellular carcinoma and hepatitis C in the United States
El-Serag, H. B. (2002) · Hepatology · doi:10.1002/hep.1840360710 · Cited by 291
Racial differences in responses to therapy with interferon in chronic hepatitis C
Reddy, R. K., Hoofnagle, J. H., Tong, M. J., Lee, W. M., Pockros, P., Heathcote, J. E., Albert, D., & Joh, T. (1999) · Hepatology · doi:10.1002/hep.510300319 · Cited by 291
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway
Heim, M. H., Moradpour, D., & Blum, H. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8469-8475.1999 · Cited by 287
Glynn, S. A. (2000) · JAMA · doi:10.1001/jama.284.2.229 · Cited by 287
Poynard, T., McHutchison, J., Davis, G. L., Esteban-Mur, R., Goodman, Z., Bedossa, P., & Albrecht, J. (2000) · Hepatology · doi:10.1053/jhep.2000.19347 · Cited by 280
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up
Neumann, U. P., Berg, T., Bahra, M., Puhl, G., Guckelberger, O., Langrehr, J. M., & Neuhaus, P. (2004) · Transplantation · doi:10.1097/01.tp.0000101738.27552.9d · Cited by 268
Steenland, K., Burnett, C., Lalich, N., Ward, E., & Hurrell, J. (2003) · American Journal of Industrial Medicine · doi:10.1002/ajim.10216 · Cited by 267
Abdel-Aziz, F., Habib, M., Mohamed, M. K., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Thomas, D., Fix, A. D., Strickland, T. G., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8438 · Cited by 265
Treatment of Hepatitis C Infection in Injection Drug Users
Backmund, M., Meyer, K., Von Zielonka, M., & Eichenlaub, D. (2001) · Hepatology · doi:10.1053/jhep.2001.25882 · Cited by 256
Schwartz, J. D., Schwartz, M., Mandeli, J., & Sung, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00873-2 · Cited by 254
Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection
Kallman, J., O’Neil, M. M., Larive, B., Boparai, N., Calabrese, L., & Younossi, Z. M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9708-x · Cited by 181
Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., & Kerr, T. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-405 · Cited by 123
Piccolo, P., Borg, L., Lin, A., Melia, D., Ho, A., & Kreek, M. J. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n04_06 · Cited by 32
José, M., Curtu, S., Gajardo, R., & Jorquera, J. I. (2003) · Biologicals · doi:10.1016/s1045-1056(02)00067-2 · Cited by 25
Hepatitis C and Individuals With Serious Mental Illnesses
Osher, F. C., Goldberg, R. W., Goodman, L. A., & Rosenberg, S. D. (2003) · Psychiatric Annals · doi:10.3928/0048-5713-20030601-09 · Cited by 10
Metadata
- Authors
- Alter, M. J.
- Venue
- Hepatology
- Published
- 1997-12
- Volume
- 26
- Issue
- Supplement 3
- Pages
- 62S-65S
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1991378085
- Cited by
- 1,075
- References
- 47
- FWCI
- 35.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.